Semaglutide is not recommended for those who are pregnant, breastfeeding, have a history of medullary thyroid cancer, pancreatitis, gallbladder disease, or a diagnosis of multiple endocrine neoplasia syndrome type 2
A Pfizer spokesman said the company is working with the Food and Drug Administration to address the open question about additional treatment and is finalizing protocols for a study of patients who may be in need of retreatment. Meanwhile, he said, the company is studying 10- and 15-day dosing options for COVID patients with symptoms who have a compromised immune system
Key Takeaways: Understanding Semaglutide: Semaglutides role in managing Type 2 diabetes and obesity is significant, offering patients a powerful tool in their treatment arsenal
Nestl was amongst the first with its line of frozen meals range, coined Vital Pursuit, which is high in protein and portion-controlled
When it comes to sleep, heres what we do: Use a questionnaire to screen for sleep apnea risk
